Re: Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: Exploratory analyses by baseline prostate-specific antigen doubling time: Editorial comment

Samir S. Taneja

    Research output: Contribution to journalComment/debate

    Original languageEnglish (US)
    Pages (from-to)421-422
    Number of pages2
    JournalJournal of Urology
    Volume192
    Issue number2
    DOIs
    StatePublished - Aug 2014

    ASJC Scopus subject areas

    • Urology

    Cite this